Improved screening of retinopathy of prematurity (ROP): development of a target product profile (TPP) for resource-limited settings
Background As more preterm infants survive, complications of preterm birth, including retinopathy of prematurity (ROP), become more prevalent.ROP rates and blindness from ROP are higher in low-income and middle-income countries, where exposure to risk factors can be higher and where detection and treatment of ROP are under-resourced or non-existent